These results were confirmed in B-CLL cell lines and primary cells, showing that PTPROt promoter activity depends on the AP-1 complex and that its inhibition is correlated with TCL1A expression [155]. This evidence concerns the gene TCL1A and B-cell chronic lymphocytic leukemia.